European Journal of Pharmacology

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

European Journal of Pharmacology

EUR J PHARMACOL

ISSN / eISSN

0014-2999 / 1879-0712

目标和范围

The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.

The scope includes:

Behavioural pharmacology
Neuropharmacology and analgesia
Cardiovascular pharmacology
Pulmonary, gastrointestinal and urogenital pharmacology
Endocrine pharmacology
Immunopharmacology and inflammation
Molecular and cellular pharmacology
Regenerative pharmacology
Biologicals and biotherapeutics
Translational pharmacology
Nutriceutical pharmacology.

研究方向

药学

CiteScore

8.70

查看趋势图

CiteScore 学科排名

类别	分区	排名
Pharmacology, Toxicology and Pharmaceutics - Pharmacology	Q1	#52/301

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
PHARMACOLOGY & PHARMACY - SCIE	Q1

H-index

167

出版国家或地区

NETHERLANDS

出版商

Elsevier

出版周期

Weekly

出版年份

1967

年文章数

568

Open Access

通讯方式

ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

同领域相关热门期刊
近期发表文章

Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction: (2023) Yu Jiao Shi, Chen Guang Yang, Wen Bo Qiao, Yong Cheng Liu, Si Yu Liu, Guo Ju Dong

Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP: (2023) Yannan Xia, Shujie Zhang, Hongyi Luo, Yumeng Wang, Yuanyuan Jiang, Jingwei Jiang, Shengtao Yuan

Promoting reverse cholesterol transport contributes to the amelioration of atherosclerosis by paeoniflorin: (2023) Ruo Man Wu, Chun Yan Wang, Jie Wang, Xiao Le Xu

Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS/CaMKII pathway: (2023) Feng Li, Ling-Ling Qian, Li-Da Wu, Zhen-Ye Zhang, Lei Zhang, Huan-Huan Liu, Ning Zhao, Jie Zhang, Jia-Yi Chen, Fan Yang, Zhi-Yuan Zhang, Chao Wang, Sh...

A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders: (2023) Axiang Li, Weifen Li, Tahir Ali, Canyu Yang, Zizhen Liu, Ruyan Gao, Kaiwu He, Xin-an Liu, Zuxin Chen, Zhi-Jian Yu, Tao Li, Shupeng Li

β-glucan, a specific immuno-stimulant, produces rapid antidepressant effects by stimulating ERK1/2-dependent synthesis of BDNF in the hippocampus: (2023) Bingran Chen, Cheng Zhao, Haojie Zhu, Xu Lu, Huijun Liu, Qun Lu, Tao Zhu, Chao Huang

The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia: (2023) Rafaela Mostallino, Michele Santoni, Claudia Sagheddu, Valentina Serra, Valeria Orrù, Marco Pistis, M. Paola Castelli

A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitis: (2023) Abdulaziz H. Alanazi, Daniel B. Chastain, Madhuri Rudraraju, Varun Parvathagiri, Shengshuai Shan, Xiaorong Lin, Andrés F. Henao-Martínez, Carlos Franc...

Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice: (2023) Amanda Marie Vanslette, Pernille Baumann Toft, Mari Lilith Lund, Thomas Moritz, Tulika Arora

GPR146 regulates pulmonary vascular remodeling by promoting pulmonary artery smooth muscle cell proliferation through 5-lipoxygenase: (2023) Jie Huang, Yongpeng Xie, Bing Chen, Yu Xia, Yanjiao Jiang, Zengxian Sun, Yun Liu

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

05 Aug 2022 Submitted
06 Aug 2022 With editor
12 Aug 2022 Under review
18 Aug 2022 Under review
20 Aug 2022 Under review
04 Sep 2022 Required Reviews Completed
05 Sep 2022 Decision in Process
06 Sep 2022 Major Revision
16 Sep 2022 Revision submitted
16 Sep 2022 With Editor
18 Sep 2022 Under Review
19 Sep 2022 Decision in Process
21 Sep 2022 Accept

Translation:
05 Aug 2022 Submitted
06 Aug 2022 With editor
12 Aug 2022 Under review
18 Aug 2022 Under review
20 Aug 2022 Under review
04 Sep 2022 Required Reviews Completed
05 Sep 2022 Decision in Process
06 Sep 2022 Major Revision
16 Sep 2022 Revision submitted
16 Sep 2022 With Editor
18 Sep 2022 Under Review
19 Sep 2022 Decision in Process
21 Sep 2022 Accept

2022-09-22

The editing process is fast. I had two reviewers for the first review, major revisions were made. For the second review, an additional reviewer was added, minor revisions were made. For the third review, minor revisions were made. After the third round of revisions, the editor accepted the paper one week later. Then, approximately one week later, it will be officially published online. This is my first undergraduate review article, so let's do our best! I wish everyone a successful acceptance as well.

2023-04-02

查看所有评论

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started